Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Total Liabilities
Everything the company owes to creditors and other parties.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities of $13.51M in Q2 FY2026
Q2 FY2026 total liabilities was $13.51M.
Context
- Total liabilities amounted to 2.9% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 371.42M USD
- Year-over-year change
- —
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 371.42M | — |
Total Liabilities vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 total liabilities of $13.51M is the 4th highest of the 5 companies compared; the peer median is $60.21M.
- Total liabilities amounts to 2.9% of total assets for COAG, versus a peer median of 10.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $629.36M | +10.1% | +39.8% | 80.8% | |
IRONDisc Medicine, Inc. | Sep 2026 | $95.24M | +66.9% | +41.6% | 13.6% |
DMRADamora Therapeutics, Inc. | Mar 2026 | $25.18M | +734.9% | +20.8% | 4.7% |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $13.51M | — | — | 2.9% |
| Mar 2026 | $4.2M | +7.3% | -27.1% | 7.7% | |
| Peer median (excluding COAG) | $60.21M | +38.5% | +30.3% | 10.7% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.